伴放线放线杆菌是类风湿性关节炎的病因吗？还有哪些未解之谜？

11 January 2022


Sung Cheng Looh, Zoey May Pheng Soo, Jia Jia Wong, Hok Chai Yam, Sook Khuan Chow, Jung Shan Hwang

下载完整 PDF 在此查看研究
复制引用
已复制！

摘要

Leukotoxin A (LtxA) is the major virulence factor of an oral bacterium known as Aggregatibacter actinomycetemcomitans (Aa). LtxA is associated with elevated levels of anti-citrullinated protein antibodies (ACPA) in rheumatoid arthritis (RA) patients. LtxA targets leukocytes and triggers an influx of extracellular calcium into cytosol. The current proposed model of LtxA-mediated hypercitrullination involves the dysregulated activation of peptidylarginine deiminase (PAD) enzymes to citrullinate proteins, the release of hypercitrullinated proteins through cell death, and the production of autoantigens recognized by ACPA. Although model-based evidence is yet to be established, its interaction with the host’s immune system sparked interest in the role of LtxA in RA. The first part of this review summarizes the current knowledge of Aa and LtxA. The next part highlights the findings of previous studies on the association of Aa or LtxA with RA aetiology. Finally, we discuss the unresolved aspects of the proposed link between LtxA of Aa and RA.

参考资料

  1. Klinger, R. (1912). Untersuchungen über menschliche aktinomykose [Investigations on human actinomycosis]. Zentralblatt für Bakteriologie, 62, 191–200.
  2. Topley, W. W. C., & Wilson, G. S. (1929). The principles of bacteriology and immunity (Vol. 1). Edward Arnold & Co.
  3. Potts, T. V., Zambon, J. J., & Genco, R. J. (1985). Reassignment of Actinobacillus actinomycetemcomitans to the genus Haemophilus as Haemophilus actinomycetemcomitans comb. nov. International Journal of Systematic Bacteriology, 35(3), 337–341. https://doi.org/10.1099/00207713-35-3-337
  4. Nørskov-Lauritsen, N., & Kilian, M. (2006). Reclassification of Actinobacillus actinomycetemcomitans, Haemophilus aphrophilus, Haemophilus paraphrophilus and Haemophilus segnis as Aggregatibacter actinomycetemcomitans gen. nov., comb. nov., Aggregatibacter aphrophilus comb. nov. and Aggregatibacter segnis comb. nov., and emended description of Aggregatibacter aphrophilus to include V factor-dependent and V factor-independent isolates. International Journal of Systematic and Evolutionary Microbiology, 56(9), 2135–2146. https://doi.org/10.1099/ijs.0.64207-0
  5. Xuedong, Z., & Yuqing, L. (2020). Atlas of oral microbiology (2nd ed.). Springer.
  6. Raja, M., Ummer, F., & Dhivakar, C. P. (2014). Aggregatibacter actinomycetemcomitans—A tooth killer. Journal of Clinical and Diagnostic Research, 8(8), ZE13–ZE16. https://doi.org/10.7860/JCDR/2014/9546.4769
  7. National Center for Biotechnology Information. (2021). Aggregatibacter actinomycetemcomitans strain VT1169, complete genome - nucleotide - NCBI. U.S. National Library of Medicine. https://www.ncbi.nlm.nih.gov/nuccore/NZ_CP012958.1
  8. Kaplan, J. B., Perry, M. B., MacLean, L. L., Furgang, D., Wilson, M. E., & Fine, D. H. (2001). Structural and genetic analyses of O polysaccharide from Actinobacillus actinomycetemcomitans serotype f. Infection and Immunity, 69(9), 5375–5384. https://doi.org/10.1128/IAI.69.9.5375-5384.2001
  9. Nørskov-Lauritsen, N., Claesson, R., Jensen, A. B., Åberg, C. H., & Haubek, D. (2019). Aggregatibacter actinomycetemcomitans: Clinical significance of a pathobiont subjected to ample changes in classification and nomenclature. Pathogens, 8(4), Article 243. https://doi.org/10.3390/pathogens8040243
  10. Suprith, S., Setty, S., Bhat, K., & Thakur, S. (2018). Serotypes of Aggregatibacter actinomycetemcomitans in relation to periodontal status and assessment of leukotoxin in periodontal disease: A clinico-microbiological study. Journal of Indian Society of Periodontology, 22(3), 201–208. https://doi.org/10.4103/jisp.jisp_387_17
  11. Christersson, L. A. (1993). Actinobacillus actinomycetemcomitans and localized juvenile periodontitis: Clinical, microbiologic and histologic studies. Swedish Dental Journal Supplement, 90, 1–46.
  12. Haubek, D., Ennibi, O. K., Poulsen, K., Poulsen, S., Benzarti, N., & Kilian, M. (2001). Early-onset periodontitis in Morocco is associated with the highly leukotoxic clone of Actinobacillus actinomycetemcomitans. Journal of Dental Research, 80(6), 1580–1583. https://doi.org/10.1177/00220345010800061901
  13. Fine, D. H., Markowitz, K., Fairlie, K., Tischio-Bereski, D., Ferrendiz, J., Furgang, D., Paster, B. J., & Dewhirst, F. E. (2013). A consortium of Aggregatibacter actinomycetemcomitans, Streptococcus parasanguinis, and Filifactor alocis is present in sites prior to bone loss in a longitudinal study of localized aggressive periodontitis. Journal of Clinical Microbiology, 51(9), 2850–2861. https://doi.org/10.1128/JCM.00750-13
  14. Fine, D. H., Patil, A. G., & Velusamy, S. K. (2019). Aggregatibacter actinomycetemcomitans (Aa) under the radar: Myths and misunderstandings of Aa and its role in aggressive periodontitis. Frontiers in Immunology, 10, Article 728. https://doi.org/10.3389/fimmu.2019.00728
  15. Tsai, C. C., McArthur, W. P., Baehni, P. C., Hammond, B. F., & Taichman, N. S. (1979). Extraction and partial characterization of a leukotoxin from a plaque-derived gram-negative microorganism. Infection and Immunity, 25(2), 427–439. https://doi.org/10.1128/iai.25.2.427-439.1979
  16. Balashova, N. V., Crosby, J. A., Al Ghofaily, L., & Kachlany, S. C. (2006). Leukotoxin confers beta-hemolytic activity to Actinobacillus actinomycetemcomitans. Infection and Immunity, 74(4), 2015–2021. https://doi.org/10.1128/IAI.74.4.2015-2021.2006
  17. Johansson, A. (2011). Aggregatibacter actinomycetemcomitans leukotoxin: A powerful tool with capacity to cause imbalance in the host inflammatory response. Toxins, 3(3), 242–259. https://doi.org/10.3390/toxins3030242
  18. Petersen, P. E., & Ogawa, H. (2012). The global burden of periodontal disease: Towards integration with chronic disease prevention and control. Periodontology 2000, 60(1), 15–39. https://doi.org/10.1111/j.1600-0757.2011.00425.x
  19. Claesson, R., Johansson, A., Belibasakis, G., Hänström, L., & Kalfas, S. (2002). Release and activation of matrix metalloproteinase 8 from human neutrophils triggered by the leukotoxin of Actinobacillus actinomycetemcomitans. Journal of Periodontal Research, 37(5), 353–359. https://doi.org/10.1034/j.1600-0765.2002.01601.x
  20. Kelk, P., Abd, H., Claesson, R., Sandström, G., Sjöstedt, A., & Johansson, A. (2011). Cellular and molecular response of human macrophages exposed to Aggregatibacter actinomycetemcomitans leukotoxin. Cell Death & Disease, 2(4), Article e126. https://doi.org/10.1038/cddis.2011.6
  21. Hirschfeld, J., Roberts, H. M., Chapple, I. L. C., Parčina, M., Jepsen, S., Johansson, A., & Claesson, R. (2016). Effects of Aggregatibacter actinomycetemcomitans leukotoxin on neutrophil migration and extracellular trap formation. Journal of Oral Microbiology, 8(1), Article 33070. https://doi.org/10.3402/jom.v8.33070
  22. Konig, M. F., Abusleme, L., Reinholdt, J., Palmer, R. J., Teles, R. P., Sampson, K., Rosen, A., Nigrovic, P. A., Sokolove, J., Giles, J. T., & Andrade, F. (2016). Aggregatibacter actinomycetemcomitans-induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis. Science Translational Medicine, 8(369), Article 369ra176. https://doi.org/10.1126/scitranslmed.afg1661
  23. Sampathkumar, V., Velusamy, S. K., Godboley, D., & Fine, D. H. (2017). Increased leukotoxin production: Characterization of 100 base pairs within the 530 base pair leukotoxin promoter region of Aggregatibacter actinomycetemcomitans. Scientific Reports, 7(1), Article 1887. https://doi.org/10.1038/s41598-017-02058-2
  24. Haubek, D., Ennibi, O. K., Poulsen, K., Væth, M., Poulsen, S., & Kilian, M. (2008). Risk of aggressive periodontitis in adolescent carriers of the JP2 clone of Aggregatibacter (Actinobacillus) actinomycetemcomitans in Morocco: A prospective longitudinal cohort study. The Lancet, 371(9608), 237–242. https://doi.org/10.1016/S0140-6736(08)60135-X
  25. Höglund Åberg, C., Kwamin, F., Claesson, R., Dahlén, G., Johansson, A., & Haubek, D. (2014). Progression of attachment loss is strongly associated with presence of the JP2 genotype of Aggregatibacter actinomycetemcomitans: A prospective cohort study of a young adolescent population. Journal of Clinical Periodontology, 41(3), 232–241. https://doi.org/10.1111/jcpe.12217
  26. Kachlany, S. C. (2010). Aggregatibacter actinomycetemcomitans leukotoxin: From threat to therapy. Journal of Chemical Biology, 89(6), 561–570. https://doi.org/10.1177/0022034510363253
  27. Lally, E. T., Golub, E. E., Kieba, I. R., Taichman, N. S., Decker, S., Berthold, P., Gibson, C. W., Demuth, D. R., & Rosenbloom, J. (1991). Structure and function of the B and D genes of the Actinobacillus actinomycetemcomitans leukotoxin complex. Microbial Pathogenesis, 11(2), 111–121. https://doi.org/10.1016/0882-4010(91)90074-S
  28. Lally, E. T., Kieba, I. R., Golub, E. E., Lear, J. D., & Tanaka, J. C. (1996). Structure/function aspects of Actinobacillus actinomycetemcomitans leukotoxin. Journal of Periodontology, 67(3), 298–308. https://doi.org/10.1902/jop.1996.67.3.298
  29. Brown, A. C., Balashova, N. V., Epand, R. M., Epand, R. F., Bragin, A., Kachlany, S. C., Walters, M. J., Du, Y., Boesze-Battaglia, K., & Lally, E. T. (2013). Aggregatibacter actinomycetemcomitans leukotoxin utilizes a cholesterol recognition/amino acid consensus site for membrane association. Journal of Biological Chemistry, 288(33), 23607–23621. https://doi.org/10.1074/jbc.M113.486241
  30. Stanley, P., Packman, L. C., Koronakis, V., & Hughes, C. (1994). Fatty acylation of two internal lysine residues required for the toxic activity of Escherichia coli hemolysin. Science, 266(5193), 1992–1996. https://doi.org/10.1126/science.7801129
  31. Balashova, N. V., Shah, C., Patel, J. K., Megalla, S., & Kachlany, S. C. (2009). Aggregatibacter actinomycetemcomitans LtxC is required for leukotoxin activity and initial interaction between toxin and host cells. Gene, 443(1-2), 42–47. https://doi.org/10.1016/j.gene.2009.05.004
  32. Sato, N., Takahashi, K., Ohta, H., Kurihara, H., Fukui, K., Murayama, Y., & Taniguchi, S. (1993). Effect of $\text{Ca}^{2+}$ on the binding of Actinobacillus actinomycetemcomitans leukotoxin and the cytotoxicity to promyelocytic leukemia HL-60 cells. Biochemistry and Molecular Biology International, 29(5), 899–805.
  33. Kraig, E., Dailey, T., & Kolodrubetz, D. (1990). Nucleotide sequence of the leukotoxin gene from Actinobacillus actinomycetemcomitans: Homology to the alpha-hemolysin/leukotoxin gene family. Infection and Immunity, 58(4), 920–929. https://doi.org/10.1128/iai.58.4.920-929.1990
  34. Hogg, N., Smith, A., McDowall, A., Giles, K., Stanley, P., & Laschinger, M. (2004). How T cells use LFA-1 to attach and migrate. Immunology Letters, 92(1-2), 51–54. https://doi.org/10.1016/j.imlet.2003.11.015
  35. Walling, B. L., & Kim, M. (2018). LFA-1 in T cell migration and differentiation. Frontiers in Immunology, 9, Article 952. https://doi.org/10.3389/fimmu.2018.00952
  36. Dileepan, T., Kachlany, S. C., Balashova, N. V., Patel, J., & Maheswaran, S. K. (2007). Human CD18 is the functional receptor for Aggregatibacter actinomycetemcomitans leukotoxin. Infection and Immunity, 75(10), 4851–4856. https://doi.org/10.1128/IAI.00581-07
  37. Kieba, I. R., Fong, K. P., Tang, H.Y., Hoffman, K. E., Speicher, D. W., Klickstein, L. B., & Lally, E. T. (2007). Aggregatibacter actinomycetemcomitans leukotoxin requires $\beta$-sheets 1 and 2 of the human CD11a $\beta$-propeller for cytotoxicity. Cellular Microbiology, 9(11), 2689–2699. https://doi.org/10.1111/j.1462-5822.2007.01000.x
  38. Shimaoka, M., Xiao, T., Liu, J. H., Yang, Y., Dong, Y., Jun, C. D., McCormack, A., Zhang, R., Joachimiak, A., Takagi, J., & Springer, T. A. (2003). Structures of the $\alpha_\text{L}$ I domain and its complex with ICAM-1 reveal a shape-shifting pathway for integrin regulation. Cell, 112(1), 99–111. https://doi.org/10.1016/S0092-8674(02)01257-6
  39. Kachlany, S. C., Schwartz, A. B., Balashova, N. V., Hioe, C. E., Tuen, M., Le, A., Kaur, M., Mei, Y., & Rao, J. (2010). Anti-leukemia activity of a bacterial toxin with natural specificity for LFA-1 on white blood cells. Leukemia Research, 34(6), 777–785. https://doi.org/10.1016/j.leukres.2009.09.020
  40. Nygren, P., Balashova, N., Brown, A. C., Kieba, I., Dhingra, A., Boesze-Battaglia, K., & Lally, E. T. (2019). Aggregatibacter actinomycetemcomitans leukotoxin causes activation of lymphocyte function‐associated antigen 1. Cellular Microbiology, 21(5), Article e12967. https://doi.org/10.1111/cmi.12967
  41. Campagnola, G., Brown, A. C., Boesze-Battaglia, K., Du, Y., Stefano, F. P., Kieba, I. R., Epand, R. F., Kakalis, L., Yeagle, P. L., Epand, R. M., & Lally, E. T. (2012). Aggregatibacter actinomycetemcomitans leukotoxin cytotoxicity occurs through bilayer destabilization. Cellular Microbiology, 14(6), 869–881. https://doi.org/10.1111/j.1462-5822.2012.01763.x
  42. Bouillot, S., Reboud, E., & Huber, P. (2018). Functional consequences of calcium influx promoted by bacterial pore-forming toxins. Toxins, 10(10), Article 387. https://doi.org/10.3390/toxins10100387
  43. Fong, K. P., Pacheco, C. M. F., Otis, L. L., Baranwal, S., Kieba, I. R., Harrison, G., Hersh, E. V., Boesze-Battaglia, K., & Lally, E. T. (2006). Actinobacillus actinomycetemcomitans leukotoxin requires lipid microdomains for target cell cytotoxicity. Cellular Microbiology, 8(11), 1753–1767. https://doi.org/10.1111/j.1462-5822.2006.00745.x
  44. Fong, K. P., Tang, H. Y., Brown, A. C., Kieba, I. R., Speicher, D. W., Boesze-Battaglia, K., & Lally, E. T. (2011). Aggregatibacter actinomycetemcomitans leukotoxin is post-translationally modified by addition of either saturated or hydroxylated fatty acyl chains. Molecular Oral Microbiology, 26(4), 262–276. https://doi.org/10.1111/j.2041-1014.2011.00615.x
  45. Korostoff, J., Yamaguchi, N., Miller, M., Kieba, I., & Lally, E. T. (2000). Perturbation of mitochondrial structure and function plays a central role in Actinobacillus actinomycetemcomitans leukotoxin-induced apoptosis. Microbial Pathogenesis, 29(5), 267–278. https://doi.org/10.1006/mpat.2000.0387
  46. Vega, B. A., Schober, L. T., Kim, T., Belinka, B. A., & Kachlany, S. C. (2019). Aggregatibacter actinomycetemcomitans Leukotoxin (LtxA) requires death receptor Fas, in addition to LFA-1, to trigger cell death in T lymphocytes. Infection and Immunity, 87(3), e00785-18. https://doi.org/10.1128/IAI.00785-18
  47. Vega, B. A., Belinka, B. A., Jr., & Kachlany, S. C. (2019). Aggregatibacter actinomycetemcomitans leukotoxin (LtxA; Leukothera®): Mechanisms of action and therapeutic applications. Toxins, 11(9), Article 489. https://doi.org/10.3390/toxins11090489
  48. Johansson, A., Hänström, L., & Kalfas, S. (2000). Inhibition of Actinobacillus actinomycetemcomitans leukotoxicity by bacteria from the subgingival flora. Oral Microbiology and Immunology, 15(4), 218–225. https://doi.org/10.1034/j.1399-302x.2000.150403.x
  49. Johansson, A., Claesson, R., Hänström, L., Sandström, G., & Kalfas, S. (2000). Polymorphonuclear leukocyte degranulation induced by leukotoxin from Actinobacillus actinomycetemcomitans. Journal of Periodontal Research, 35(2), 85–92. https://doi.org/10.1034/j.1600-0765.2000.035002085.x
  50. Furugen, R., Hayashida, H., Yoshii, Y., & Saito, T. (2011). Neutrophil-derived resistin release induced by Aggregatibacter actinomycetemcomitans. FEMS Microbiology Letters, 321(2), 175–182. https://doi.org/10.1111/j.1574-6968.2011.02327.x
  51. Aulik, N.A., Hellenbrand, K. M., Klos, H., & Czuprynski, C. J. (2010). Mannheimia haemolytica and its leukotoxin cause neutrophil extracellular trap formation by bovine neutrophils. Infection and Immunity, 78(10), 4454–4466. https://doi.org/10.1128/IAI.00340-10
  52. Palmer, L. J., Cooper, P. R., Ling, M. R., Wright, H. J., Huissoon, A., & Chapple, I. L. C. (2012). Hypochlorous acid regulates neutrophil extracellular trap release in humans. Clinical & Experimental Immunology, 167(2), 261–268. https://doi.org/10.1111/j.1365-2249.2011.04502.x
  53. Papayannopoulos, V. (2018). Neutrophil extracellular traps in immunity and disease. Nature Reviews Immunology, 18(2), 134–147. https://doi.org/10.1038/nri.2017.105
  54. Winning, L., & Linden, G. J. (2017). Periodontitis and systemic disease: Association or causality? Current Oral Health Reports, 4(1), 1–7. https://doi.org/10.1007/s40496-017-0121-7
  55. Demmer, R. T., Molitor, J. A., Jacobs, D. R., & Michalowicz, B. S. (2011). Periodontal disease, tooth loss and incident rheumatoid arthritis: Results from the First National Health and Nutrition Examination Survey and its epidemiological follow-up study. Journal of Clinical Periodontology, 38(11), 998–1006. https://doi.org/10.1111/j.1600-051X.2011.01776.x
  56. Almutairi, K., Nossent, J., Preen, D., Keen, H., & Inderjeeth, C. (2021). The global prevalence of rheumatoid arthritis: A meta-analysis based on a systematic review. Rheumatology International, 41(5), 863–877. https://doi.org/10.1007/s00296-020-04731-0
  57. Xu, B., & Lin, J. (2017). Characteristics and risk factors of rheumatoid arthritis in the United States: An NHANES analysis. PeerJ, 5, Article e4035. https://doi.org/10.7717/peerj.4035
  58. Pradhan-Palikhe, P., Mäntylä, P., Paju, S., Buhlin, K., Persson, G. R., Nieminen, M. S., Sinisalo, J., & Pussinen, P. J. (2013). Subgingival bacterial burden in relation to clinical and radiographic periodontal parameters. Journal of Periodontology, 84(12), 1809–1817. https://doi.org/10.1902/jop.2013.120573
  59. Rannou, F., François, M., Corvol, M. T., & Berenbaum, F. (2006). Cartilage breakdown in rheumatoid arthritis. Joint Bone Spine, 73(1), 29–36. https://doi.org/10.1016/j.jbspin.2005.01.011
  60. Salari, M. H., & Kadkhoda, Z. (2004). Rate of cultivable subgingival periodontopathogenic bacteria in chronic periodontitis. Journal of Oral Science, 46(3), 157–161. https://doi.org/10.2334/josnusd.46.157
  61. Hirsch, R., Deng, H., & Laohachai, M. N. (2012). Azithromycin in periodontal treatment: More than an antibiotic. Journal of Periodontal Research, 47(2), 137–148. https://doi.org/10.1111/j.1600-0765.2011.01414.x
  62. Teughels, W., Dhondt, R., Dekeyser, C., & Quirynen, M. (2014). Treatment of aggressive periodontitis. Periodontology 2000, 65(1), 107–133. https://doi.org/10.1111/prd.12020
  63. Prakasam, A., Elavarasu, S. S., & Natarajan, R. K. (2012). Antibiotics in the management of aggressive periodontitis. Journal of Pharmacy & Bioallied Sciences, 4(Suppl. 2), S252–S255. https://doi.org/10.4103/0975-7406.100251
  64. Martinez-Martinez, R. E., Abud-Mendoza, C., Patiño-Marin, N., Rizo-Rodríguez, J. C., Little, J. W., & Loyola-Rodríguez, J. P. (2009). Detection of periodontal bacterial DNA in serum and synovial fluid in refractory rheumatoid arthritis patients. Journal of Clinical Periodontology, 36(12), 1004–1010. https://doi.org/10.1111/j.1600-051X.2009.01491.x
  65. Ogrendik, M. (2009). Rheumatoid arthritis is linked to oral bacteria: Etiological association. Modern Rheumatology, 19(5), 453–456. https://doi.org/10.1007/s10165-009-0194-9
  66. Zhao, Y., Chen, B., Li, S., Yang, L., Zhu, D., Wang, Y., Wang, H., Wang, T., Shi, B., Gai, Z., & Sheng, J. (2018). Detection and characterization of bacterial nucleic acids in culture-negative synovial tissue and fluid samples from rheumatoid arthritis or osteoarthritis patients. Scientific Reports, 8(1), Article 14305. https://doi.org/10.1038/s41598-018-32667-4
  67. Mukherjee, A., Jantsch, V., Khan, R., Hartung, W., Fischer, R., Jantsch, J., Ehrenstein, B., Konig, M. F., & Andrade, F. (2018). Rheumatoid arthritis-associated autoimmunity due to Aggregatibacter actinomycetemcomitans and its resolution with antibiotic therapy. Frontiers in Immunology, 9, Article 2352. https://doi.org/10.3389/fimmu.2018.02352
  68. Araújo, V. M. A., Melo, I. M., & Lima, V. (2015). Relationship between periodontitis and rheumatoid arthritis: Review of the literature. Mediators of Inflammation, 2015, Article 259074. https://doi.org/10.1155/2015/259074
  69. Baltacıoğlu, E., Akalın, F. A., Alver, A., Değer, O., & Karabulut, E. (2008). Protein carbonyl levels in serum and gingival crevicular fluid in patients with chronic periodontitis. Archives of Oral Biology, 53(8), 716–722. https://doi.org/10.1016/j.archoralbio.2008.02.002
  70. Pradeep, A. R., Raghavendra, N. M., Prasad, M. V. R., Kathariya, R., Patel, S. P., & Sharma, A. (2011). Gingival crevicular fluid and serum visfatin concentration: Their relationship in periodontal health and disease. Journal of Periodontology, 82(9), 1314–1319. https://doi.org/10.1902/jop.2011.100690
  71. Thorat, M. K., & Pradeep, A. R. (2010). Correlation of levels of oncostatin M cytokine in crevicular fluid and serum in periodontal disease. International Journal of Oral Science, 2(4), 198–207. https://doi.org/10.4248/IJOS10073
  72. Kalburgi, V., Sravya, L., Warad, S., Vijayalaxmi, K., Sejal, P., & Hazeil, D. (2014). Role of systemic markers in periodontal diseases: A possible inflammatory burden and risk factor for cardiovascular diseases? Annals of Medical and Health Sciences Research, 4(3), 388–392. https://doi.org/10.4103/2141-9248.133461
  73. Shrivastava, A. K., Singh, H. V., Raizada, A., Singh, S. K., Pandey, A., Singh, N., Yadav, D. S., & Sharma, H. (2015). Inflammatory markers in patients with rheumatoid arthritis. Allergologia et Immunopathologia, 43(1), 81–87. https://doi.org/10.1016/j.aller.2013.11.003
  74. Brennan, F. M., & McInnes, I. B. (2008). Evidence that cytokines play a role in rheumatoid arthritis. Journal of Clinical Investigation, 118(11), 3537–3545. https://doi.org/10.1172/JCI36389
  75. Nesse, W., Westra, J., van der Wal, J. E., Abbas, F., Nicholas, A. P., Vissink, A., & Brouwer, E. (2012). The periodontium of periodontitis patients contains citrullinated proteins which may play a role in ACPA (anti-citrullinated protein antibody) formation. Journal of Clinical Periodontology, 39(7), 599–607. https://doi.org/10.1111/j.1600-051X.2012.01885.x
  76. de Smit, M. J., Rahajoe, P. S., Schuurmans, G. J., Eelsing, E., Kertia, N., Vissink, A., & Westra, J. (2018). Rheumatoid arthritis (RA)-associated autoantibodies are present in the periodontal exudate of patients with and without RA. Annals of the Rheumatic Diseases, 77(8), 1253–1254. https://doi.org/10.1136/annrheumdis-2017-212711
  77. Terao, C., Asai, K., Hashimoto, M., Yamazaki, T., Ohmura, K., Yamaguchi, A., Takahashi, K., Takei, N., Ishii, T., Kawaguchi, T., ... Nagahama Study Group. (2015). Significant association of periodontal disease with anti-citrullinated peptide antibody in a Japanese healthy population—The Nagahama study. Journal of Autoimmunity, 59, 85–90. https://doi.org/10.1016/j.jaut.2015.02.006
  78. de Pablo, P., Chapple, I. L. C., Buckley, C. D., & Dietrich, T. (2009). Periodontitis in systemic rheumatic diseases. Nature Reviews Rheumatology, 5(4), 218–224. https://doi.org/10.1038/nrrheum.2009.28
  79. Wegner, N., Lundberg, K., Kinloch, A., Fisher, B., Malmström, V., Feldmann, M., & Venables, P. J. (2010). Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunological Reviews, 233(1), 34–54. https://doi.org/10.1111/j.1600-065X.2009.00850.x
  80. Gonzalez, S. M., Payne, J. B., Yu, F., Thiele, G. M., Erickson, A. R., Johnson, P. G., Schmid, M. J., Cannon, G. W., Kerr, G. S., Reimold, A. M., ... Mikuls, T. R. (2015). Alveolar bone loss is associated with circulating anti-citrullinated protein antibody (ACPA) in patients with rheumatoid arthritis. Journal of Periodontology, 86(2), 222–231. https://doi.org/10.1902/jop.2014.140234
  81. Lappin, D. F., Apatzidou, D., Quirke, A. M., Oliver-Bell, J., Butcher, J. P., Kinane, D. F., Riggio, M. P., Venables, P., McInnes, I. B., & Culshaw, S. (2013). Influence of periodontal disease, Porphyromonas gingivalis and cigarette smoking on systemic anti-citrullinated peptide antibody titres. Journal of Clinical Periodontology, 40(10), 907–915. https://doi.org/10.1111/jcpe.12134
  82. van der Helm-van Mil, A. H. M., Verpoort, K. N., Breedveld, F. C., Toes, R. E. M., & Huizinga, T. W. J. (2005). Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis. Arthritis Research & Therapy, 7(5), R949–R958. https://doi.org/10.1186/ar1767
  83. Shi, J., Knevel, R., Suwannalai, P., van der Linden, M. P., Janssen, G. M. C., van Veelen, P. A., Levarht, N. E. W., van der Helm-van Mil, A. H. M., Cerami, A., Huizinga, T. W. J., ... Toes, R. E. (2011). Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. Proceedings of the National Academy of Sciences, 108(42), 17372–17377. https://doi.org/10.1073/pnas.1114455108
  84. Juarez, M., Bang, H., Hammar, F., Reimer, U., Dyke, B., Sahbudin, I., Buckley, C. D., Fisher, B., Filer, A., & Raza, K. (2016). Identification of novel antiacetylated vimentin antibodies in patients with early inflammatory arthritis. Annals of the Rheumatic Diseases, 75(6), 1099–1107. https://doi.org/10.1136/annrheumdis-2014-207185
  85. Kässer, U. R., Michel, A., Bolten, W. W., Gleissner, C., Dehne, F., & Willershausen-Zönnchen, B. (1997). Risk for periodontal disease in patients with longstanding rheumatoid arthritis. Arthritis & Rheumatism, 40(12), 2248–2251. https://doi.org/10.1002/art.1780401221
  86. de Pablo, P., Dietrich, T., & McAlindon, T. E. (2008). Association of periodontal disease and tooth loss with rheumatoid arthritis in the US population. The Journal of Rheumatology, 35(1), 70–76.
  87. Havemose-Poulsen, A., Westergaard, J., Stoltze, K., Skjødt, H., Danneskiold-Samsøe, B., Locht, H., Bendtzen, K., & Holmstrup, P. (2006). Periodontal and hematological characteristics associated with aggressive periodontitis, juvenile idiopathic arthritis, and rheumatoid arthritis. Journal of Periodontology, 77(2), 280–288. https://doi.org/10.1902/jop.2006.050065
  88. Pischon, N., Pischon, T., Kröger, J., Gülmez, E., Kleber, B. M., Bernimoulin, J. P., Landau, H., Brinkmann, P. G., Schlattmann, P., Zernicke, J., ... Purucker, P. (2008). Association among rheumatoid arthritis, oral hygiene, and periodontitis. Journal of Periodontology, 79(6), 979–986. https://doi.org/10.1902/jop.2008.070501
  89. Mercado, F., Marshall, R. I., Klestov, A. C., & Bartold, P. M. (2000). Is there a relationship between rheumatoid arthritis and periodontal disease? Journal of Clinical Periodontology, 27(4), 267–272. https://doi.org/10.1034/j.1600-051x.2000.027004267.x
  90. Mercado, F. B., Marshall, R. I., Klestov, A. C., & Bartold, P. M. (2001). Relationship between rheumatoid arthritis and periodontitis. Journal of Periodontology, 72(6), 779–787. https://doi.org/10.1902/jop.2001.72.6.779
  91. Kobayashi, T., Yokoyama, T., Ishida, K., Abe, A., Yamamoto, K., & Yoshie, H. (2010). Serum cytokine and periodontal profiles in relation to disease activity of rheumatoid arthritis in Japanese adults. Journal of Periodontology, 81(5), 650–657. https://doi.org/10.1902/jop.2010.090624
  92. Marotte, H., Farge, P., Gaudin, P., Alexandre, C., Mougin, B., & Miossec, P. (2006). The association between periodontal disease and joint destruction in rheumatoid arthritis extends the link between the HLA-DR shared epitope and severity of bone destruction. Annals of the Rheumatic Diseases, 65(7), 905–909. https://doi.org/10.1136/ard.2005.045617
  93. Dissick, A., Redman, R. S., Jones, M., Rangan, B. V., Reimold, A., Griffiths, G. R., Mikuls, T. R., Amdur, R. L., Richards, J. S., & Kerr, G. S. (2010). Association of periodontitis with rheumatoid arthritis: A pilot study. Journal of Periodontology, 81(2), 223–230. https://doi.org/10.1902/jop.2009.090309
  94. Rodríguez-Lozano, B., González-Febles, J., Garnier-Rodríguez, J. L., Dadlani, S., Bustabad-Reyes, S., Sanz, M., Sánchez-Alonso, F., Sánchez-Piedra, C., González-Dávila, E., & Díaz-González, F. (2019). Association between severity of periodontitis and clinical activity in rheumatoid arthritis patients: A case-control study. Arthritis Research & Therapy, 21(1), Article 27. https://doi.org/10.1186/s13075-019-1811-1
  95. Rajkarnikar, J., Thomas, B. S., & Rao, S. K. (2013). Inter-relationship between rheumatoid arthritis and periodontitis. Kathmandu University Medical Journal, 11(1), 22–26. https://doi.org/10.3126/kumj.v11i1.11020
  96. Joseph, R., Rajappan, S., Nath, S. G., & Paul, B. J. (2013). Association between chronic periodontitis and rheumatoid arthritis: A hospital-based case-control study. Rheumatology International, 33(1), 103–109. https://doi.org/10.1007/s00296-011-2303-3
  97. Ortiz, P., Bissada, N. F., Palomo, L., Han, Y. W., Al-Zahrani, M. S., Panneerselvam, A., & Askari, A. (2009). Periodontal therapy reduces the severity of active rheumatoid arthritis in patients treated with or without tumor necrosis factor inhibitors. Journal of Periodontology, 80(4), 535–540. https://doi.org/10.1902/jop.2009.080483
  98. Erciyas, K., Sezer, U., Üstün, K., Pehlivan, Y., Kısacık, B., Şenyurt, S., Tarakçıoğlu, M., & Onat, A. (2013). Effects of periodontal therapy on disease activity and systemic inflammation in rheumatoid arthritis patients. Oral Diseases, 19(4), 394–400. https://doi.org/10.1111/odi.12017
  99. Salemi, S., Biondo, M. I., Fiorentino, C., Argento, G., Paolantonio, M., di Murro, C., Malagnino, V. A., Canzoni, M., & Diamanti, A. P. (2014). Could early rheumatoid arthritis resolve after periodontitis treatment only? Case report and review of the literature. Medicine, 93(27), Article e195. https://doi.org/10.1097/MD.0000000000000195
  100. Zhao, X., Liu, Z., Shu, D., Xiong, Y., He, M., Xu, S., Si, S., & Guo, B. (2018). Association of periodontitis with rheumatoid arthritis and the effect of non-surgical periodontal treatment on disease activity in patients with rheumatoid arthritis. Medical Science Monitor, 24, 5802–5810. https://doi.org/10.12659/MSM.909568
  101. De Pinho, N. M., Oliveira, R. D. R., Novaes, A. B., & Voltarelli, J. C. (2009). Relationship between periodontitis and rheumatoid arthritis and the effect of non-surgical periodontal treatment. Brazilian Dental Journal, 20(5), 355–364. https://doi.org/10.1590/S0103-64402009000500001
  102. Kaushal, S., Singh, A. K., Lal, N., Das, S. K., & Mahdi, A. A. (2019). Effect of periodontal therapy on disease activity in patients of rheumatoid arthritis with chronic periodontitis. Journal of Oral Biology and Craniofacial Research, 9(2), 128–132. https://doi.org/10.1016/j.jobcr.2019.02.002
  103. Cosgarea, R., Tristiu, R., Dumitru, R. B., Arweiler, N. B., Rednic, S., Sirbu, C. I., Lascu, L., Sculean, A., & Eick, S. (2019). Effects of non-surgical periodontal therapy on periodontal laboratory and clinical data as well as on disease activity in patients with rheumatoid arthritis. *Clinical Oral Investigations“, 23(1), 141–151. https://doi.org/10.1007/s00784-018-2420-2
  104. Scher, J. U., Ubeda, C., Equinda, M., Khanin, R., Buischi, Y., Viale, A., Lipuma, L., Attur, M., Pillinger, M. H., Weissmann, G., ... Littman, D. R. (2012). Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis. Arthritis & Rheumatism, 64(10), 3083–3094. https://doi.org/10.1002/art.34567
  105. Zhang, X., Zhang, D., Jia, H., Feng, Q., Wang, D., Liang, D., Wu, X., Li, J., Tang, L., Li, Y., ... Wang, J. (2015). The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nature Medicine, 21(8), 895–905. https://doi.org/10.1038/nm.3914
  106. Lopez-Oliva, I., Paropkari, A. D., Saraswat, S., Serban, S., Yonel, Z., Sharma, P., de Pablo, P., Raza, K., Filer, A., Chapple, I., ... Kumar, P. S. (2018). Dysbiotic subgingival microbial communities in periodontally healthy patients with rheumatoid arthritis. Arthritis & Rheumatology, 70(7), 1008–1013. https://doi.org/10.1002/art.40485
  107. Corrêa, J. D., Fernandes, G. R., Calderaro, D. C., Mendonça, S. M. S., Silva, J. M., Albiero, M. L., Cunha, F. Q., Xiao, E., Ferreira, G. A., Teixeira, A. L., ... Siqueira, W. L. (2019). Oral microbial dysbiosis linked to worsened periodontal condition in rheumatoid arthritis patients. Scientific Reports, 9(1), Article 8379. https://doi.org/10.1038/s41598-019-44674-4
  108. Ogrendik, M., Kokino, S., Ozdemir, F., Bird, P. S., & Hamlet, S. (2005). Serum antibodies to oral anaerobic bacteria in patients with rheumatoid arthritis. MedGenMed: Medscape General Medicine, 7(2), Article 2.
  109. Okada, M., Kobayashi, T., Ito, S., Yokoyama, T., Komatsu, Y., Abe, A., Murasawa, A., & Yoshie, H. (2011). Antibody responses to periodontopathic bacteria in relation to rheumatoid arthritis in Japanese adults. Journal of Periodontology, 82(10), 1433–1441. https://doi.org/10.1902/jop.2011.110020
  110. Kimura, Y., Yoshida, S., Takeuchi, T., Kimura, M., Yoshikawa, A., Hiramatsu, Y., Ishida, T., Makino, S., Takasugi, Y., & Hanafusa, T. (2015). Periodontal pathogens participate in synovitis in patients with rheumatoid arthritis in clinical remission: A retrospective case–control study. Rheumatology, 54(12), 2257–2263. https://doi.org/10.1093/rheumatology/kev283
  111. Moen, K., Brun, J. G., Valen, M., Skartveit, L., Eribe, E. K. R., Olsen, I., & Jonsson, R. (2006). Synovial inflammation in active rheumatoid arthritis and psoriatic arthritis facilitates trapping of a variety of oral bacterial DNAs. Clinical and Experimental Rheumatology, 24(6), 656–663.
  112. Ziebolz, D., Pabel, S. O., Lange, K., Krohn-Grimberghe, B., Hornecker, E., & Mausberg, R. F. (2011). Clinical periodontal and microbiologic parameters in patients with rheumatoid arthritis. Journal of Periodontology, 82(10), 1424–1432. https://doi.org/10.1902/jop.2011.110178
  113. Reichert, S., Haffner, M., Keyßer, G., Schäfer, C., Stein, J. M., Schaller, H. G., Wienke, A., Strauss, H., Heide, S., & Schulz, S. (2013). Detection of oral bacterial DNA in synovial fluid. Journal of Clinical Periodontology, 40(6), 591–598. https://doi.org/10.1111/jcpe.12102
  114. Ebbers, M., Lübcke, P. M., Volzke, J., Kriebel, K., Hieke, C., Engelmann, R., Lang, H., Kreikemeyer, B., & Müller-Hilke, B. (2018). Interplay between P. gingivalis, F. nucleatum and A. actinomycetemcomitans in murine alveolar bone loss, arthritis onset and progression. Scientific Reports, 8(1), Article 15129. https://doi.org/10.1038/s41598-018-33159-1
  115. Nienhuis, R. L., & Mandema, E. (1964). A new serum factor in patients with rheumatoid arthritis; the antiperinuclear factor. Annals of the Rheumatic Diseases, 23(4), 302–305. https://doi.org/10.1136/ard.23.4.302
  116. Aletaha, D., Neogi, T., Silman, A. J., Funovits, J., Felson, D. T., Bingham, C. O., 3rd, Birnbaum, N. S., Burmester, G. R., Bykerk, V. P., Cohen, M. D., ... Hawker, G. (2010). 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis & Rheumatism, 62(9), 2569–2581. https://doi.org/10.1002/art.27584
  117. Nielen, M. M. J., van Schaardenburg, D., Reesink, H. W., van de Stadt, R. J., van der Horst-Bruinsma, I. E., de Koning, M. H. M. T., Habibuw, M. R., Vandenbroucke, J. P., & Dijkmans, B. A. C. (2004). Specific autoantibodies precede the symptoms of rheumatoid arthritis: A study of serial measurements in blood donors. Arthritis & Rheumatism, 50(2), 380–386. https://doi.org/10.1002/art.20035
  118. van de Stadt, L. A., de Koning, M. H. M. T., van de Stadt, R. J., Wolbink, G., Dijkmans, B. A. C., Hamann, D., & van Schaardenburg, D. (2011). Development of the anti-citrullinated protein antibody repertoire prior to the onset of rheumatoid arthritis. *Arthritis & Rheumatism“, 63(11), 3226–3233. https://doi.org/10.1002/art.20035
  119. van der Woude, D., Syversen, S. W., van der Voort, E. I. H., Verpoort, K. N., Goll, G. L., van der Linden, M. P. M., van Mil, A. H. M., van der Heijde, D. M. F. M., Huizinga, T. W. J., Kvien, T. K., ... Toes, R. E. M. (2010). The ACPA isotype profile reflects long-term radiographic progression in rheumatoid arthritis. Annals of the Rheumatic Diseases, 69(6), 1110–1116. https://doi.org/10.1136/ard.2009.117945
  120. Kleyer, A., Finzel, S., Rech, J., Manger, B., Krieter, M., Faustini, F., Araujo, E., Hueber, A. J., Harre, U., Engelke, K., ... Schett, G. (2014). Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies. Annals of the Rheumatic Diseases, 73(5), 854–860. https://doi.org/10.1136/annrheumdis-2012-202958
  121. Loutan, L., Alpizar-Rodriguez, D., Courvoisier, D. S., Finckh, A., Mombelli, A., & Giannopoulou, C. (2019). Periodontal status correlates with anti-citrullinated protein antibodies in first-degree relatives of individuals with rheumatoid arthritis. Journal of Clinical Periodontology, 46(7), 690–698. https://doi.org/10.1111/jcpe.13123
  122. González-Febles, J., Rodríguez-Lozano, B., Sánchez-Piedra, C., Garnier-Rodríguez, J., Bustabad, S., Hernández-González, M., González-Dávila, E., Sanz, M., & Diáz-González, F. (2020). Association between periodontitis and anti-citrullinated protein antibodies in rheumatoid arthritis patients: A cross-sectional study. Arthritis Research & Therapy, 22(1), Article 27. https://doi.org/10.1186/s13075-020-2117-6
  123. Kinloch, A., Lundberg, K., Wait, R., Wegner, N., Lim, N. H., Zendman, A. J. W., Saxne, T., Malmström, V., & Venables, P. J. (2008). Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis. Arthritis & Rheumatism, 58(8), 2287–2295. https://doi.org/10.1002/art.23616

引用

Looh, S. C., Soo, Z. M. P., Wong, J. J., Yam, H. C., Chow, S. K., & Hwang, J. S. (2022). Aggregatibacter actinomycetemcomitans as the Aetiological Cause of Rheumatoid Arthritis: What Are the Unsolved Puzzles? Toxins, 14(1), 50. https://doi.org/10.3390/toxins14010050

复制引用 已复制！
下载完整 PDF 在此查看研究